Prokidney (PROK) Return on Invested Capital (2022 - 2023)

Prokidney's (PROK) quarterly Return on Invested Capital came in at 12.56% in Q1 2023, down 5.51% on a QoQ basis from 11.9% in Q4 2022.

Prokidney (PROK) Return on Invested Capital (2022 - 2023) Analysis & Trends

Prokidney (PROK) has 2 years of Return on Invested Capital data on file, last reported at 12.56% in Q1 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Oculis Holding AG	66,621.14 Bn	66,620.85 Bn	-	-
2	Nanobiotix	1,915.18 Bn	1,915.11 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.27 Bn	466.48 Bn	1.35 Bn	0.00%
5	Vertex Pharmaceuticals	121.81 Bn	114.57 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	69.58 Bn	60.82 Bn	3.31 Bn	0.04%
7	Belite Bio	62.72 Bn	62.72 Bn	-	-
8	Argenx Se	55.51 Bn	50.33 Bn	1.41 Bn	-
9	Revolution Medicines	37.35 Bn	37.35 Bn	-	-
10	Prokidney	96.00 Mn	96.00 Mn	-	-

Download Data